Scientists at the University Medical Center Hamburg-Eppendorf (UKE) and Heidelberg University Hospital (UKHD) have ...

Early diagnosis and treatment aim to minimise the impact of multiple sclerosis on their daily lives and extend their ...

With the theme 'My MS diagnosis', World MS Day 2025 on May 30 highlights the urgency of early detection, access to care, and ...

Roche Holdings AG (OTC:RHHBY) on Friday announced new 96-week data for fenebrutinib demonstrating that patients with ...

Multiple Sclerosis cases are rising in India, especially among women, with experts stressing early diagnosis, access to ...

'World Multiple Sclerosis Day' is on May 3oth. The day is meant to highlight the disease that has no cure and its effects on the millions of people who live with the condition. Officials with the ...

As aging has her experiencing estrogen loss and her MS, columnist Susan Payrovi evaluates her response to the changes she's ...

Multiple sclerosis MS a chronic neurological condition is an autoimmune disorder Scroll down to learn how to identify the ...

Roche has shared long-term phase 2 data on its BTK inhibitor fenebrutinib in relapsing multiple sclerosis (MS), | Roche has ...

As the 2017 study published in L ancet showed: Syptoms vary widely. no two experiences are the same. Fatigue, clumsiness, ...

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...